CLINICAL_TRIALS
trial_result
· 2007-12-20
Clinical Trial Update: A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia. [Phase 4]
Summary
A Phase 4 study evaluating NeoRecormon (epoetin beta) in patients with renal anemia was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 4 | Status: TERMINATED